MedTrace Logo

Cooperative Re-Engagement Controlled Trial (CoRECT)

NCT02693145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1893

Last updated 2021-02-21

No results posted yet for this study

Summary

CoRECT will help identify the important components of a data-sharing partnership between health departments and HIV care providers, and determine the extent to which a health department intervention can increase the number of HIV-infected persons out-of-care who: (a) link to an HIV clinic; (b) remain in HIV medical care; (c) achieve HIV viral load suppression within 12 months; and (d) achieve durable HIV viral load suppression over 18 months. We will also measure the cost-effectiveness of this intervention in regards to improved health in the individuals (re)-engaged in HIV care and reductions in further HIV transmission in the community.

Conditions

  • Human Immunodeficiency Virus

Interventions

OTHER

Anti-Retroviral Treatment and Access to Services (ARTAS)

Anti-Retroviral Treatment and Access to Services (ARTAS) is an individual-level, multi-session, time-limited intervention with the goal of linking recently diagnosed persons with HIV to medical care soon after receiving their positive test result. ARTAS is based on the Strengths-based Case Management (SBCM) model, which is rooted in Social Cognitive Theory (particularly self-efficacy) and Humanistic Psychology. SBCM is a model that encourages the client to identify and use personal strengths; create goals for himself/herself; and establish an effective, working relationship with the Linkage Coordinator (LC).

Sponsors & Collaborators

  • Connecticut State, Department of Mental Health and Addiction Services

    collaborator OTHER_GOV

  • Massachusetts Department of Health

    collaborator OTHER_GOV

  • Philadelphia Department of Public Health

    collaborator OTHER_GOV

  • Centers for Disease Control and Prevention

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02693145 on ClinicalTrials.gov